CRT 2024
Symposium
Equity, Inclusion, & Diversity in Interventional Cardiology [Non-CME]
Wayne Batchelor, MD, MHS
Director, Interventional Cardiology and Interventional Research and Innovation
Inova Heart & Vascular Institute
Falls Church, Virginia, United States
No relationships to disclose
Joaquin E. Cigarroa, MD
Head of the Division of Cardiovascular Medicine
OHSU Knight Cardiovascular Institute
Portland, Oregon, United States
No relationships to disclose
Aaron Horne, Jr., MD, MBA
Structural Interventionalist
Summit Health
Berkeley Heights, New Jersey, United States
Disclosure(s): AstraZeneca Pharmaceuticals: Honoraria (Ongoing); Zoll Medical: Honoraria (Ongoing)
Misti Malone, PhD
Asst Director, PIDT
FDA
Silver Spring, Maryland, United States
No relationships to disclose
James C. Blankenship, MD, MHCM, MSCAI, MACC
Director of Cardiology, University of New Mexico
University of New Mexico
Albuquerque, New Mexico, United States
No relationships to disclose
Marianne Brodmann, MD
Substitue Head of Divsion of Angiology, Medical University Graz
Medical University Graz
Graz, Steiermark, Austria
No relationships to disclose
Michael R. Jaff, DO
Chief Medical Officer
Boston Scientific Corporation
Delray Beach, Florida, United States
Disclosure information not submitted.
Michael A. Kutcher, MD
Emeritus Professor of Cardiovascular Medicine
Wake Forest University School of Medicine
Winston-Salem, North Carolina, United States
No relationships to disclose
Tracy Wang, MD MHS MSc
Chief of CER
PCORI, North Carolina, United States
Disclosure information not submitted.
Jaime Wheeler, SVP Clinical Affairs
Senior Vice President, Clinical Affairs
Edwards Lifesciences, California, United States
No relationships to disclose